Navigation Links
Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
Date:11/15/2012

MEXICO CITY, Nov. 15, 2012 /PRNewswire/ -- Grupo Casa Saba (NYSE: SAB)

Grupo Casa Saba, S.A.B. de C.V. ("GCS" or the "Company") (BMV: SAB* and NYSE: SAB) announces its intention to delist its American Depositary Shares ("ADSs") from the New York Stock Exchange ("NYSE").

GCS will concentrate all trading of its ordinary shares on the Bolsa Mexicana de Valores in Mexico ("BMV") and will be terminating its current ADS program. GCS has made a number of acquisitions over the last four fiscal years, and it has faced difficulties in integrating these businesses into its financial reporting structure, with the result that its auditors have issued qualified audit reports in three of the last four fiscal years. In determining to delist its ADSs, GCS has taken into account the low trading volume of its ADSs on the NYSE, and the associated costs of maintaining the listing and related obligations, including the increased complexities arising from its recent acquisitions.

GCS has not arranged for the listing or registration of its ADS or ordinary shares on another U.S. national securities exchange or for their quotation in a quotation medium in the United States.

GCS intends to file a Form 25 with the SEC to effect the delisting from the NYSE on or about November 26, 2012. The delisting will become effective 10 days later.

GCS will continue to be subject to reporting obligations under the U.S. Securities Exchange Act of 1934 (the "Exchange Act") until such time as it can terminate its registration under the Exchange Act. GCS will continue discussing with the SEC the resolution of the deficiencies in its financial reporting structure that have led to its auditors issuing qualified audit reports.

GCS's CEO Manuel Saba Ades commented: "GCS's delisting from The New York Stock Exchange means we can concentrate our attention and resources on a single listing on
'/>"/>

SOURCE Grupo Casa Saba, S.A.B. de C.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Perrigo Company plc ("Perrigo") (NYSE: ... of "Quality Affordable Healthcare Products®," today announced the closing ... the sale of 6,809,210 ordinary shares at a public ... exercise of the option to purchase up to an ... and Barclays Capital Inc., as representatives of the several ...
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3New Pain Management Center Opens in Cumberland, Md. 2
... 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... LLY ) today announced results from a retrospective study ... incidence of events related to cardiovascular disease (CVD) and ... to initiators of other commonly used diabetes medications. These ...
... Reportlinker.com announces that a new market research report ... Global Agricultural Biotechnology Industry ... worldwide markets for Agricultural Biotechnology in US$ Million ... Corn, Cotton, & Others (Includes Canola, Wheat, Rice, ...
Cached Medicine Technology:Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 2Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 3Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 4Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 5Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 6Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 7Reportlinker Adds Global Agricultural Biotechnology Industry 2Reportlinker Adds Global Agricultural Biotechnology Industry 3Reportlinker Adds Global Agricultural Biotechnology Industry 4Reportlinker Adds Global Agricultural Biotechnology Industry 5Reportlinker Adds Global Agricultural Biotechnology Industry 6Reportlinker Adds Global Agricultural Biotechnology Industry 7Reportlinker Adds Global Agricultural Biotechnology Industry 8Reportlinker Adds Global Agricultural Biotechnology Industry 9Reportlinker Adds Global Agricultural Biotechnology Industry 10Reportlinker Adds Global Agricultural Biotechnology Industry 11Reportlinker Adds Global Agricultural Biotechnology Industry 12Reportlinker Adds Global Agricultural Biotechnology Industry 13Reportlinker Adds Global Agricultural Biotechnology Industry 14Reportlinker Adds Global Agricultural Biotechnology Industry 15Reportlinker Adds Global Agricultural Biotechnology Industry 16Reportlinker Adds Global Agricultural Biotechnology Industry 17Reportlinker Adds Global Agricultural Biotechnology Industry 18Reportlinker Adds Global Agricultural Biotechnology Industry 19Reportlinker Adds Global Agricultural Biotechnology Industry 20Reportlinker Adds Global Agricultural Biotechnology Industry 21Reportlinker Adds Global Agricultural Biotechnology Industry 22Reportlinker Adds Global Agricultural Biotechnology Industry 23Reportlinker Adds Global Agricultural Biotechnology Industry 24
(Date:11/27/2014)... 2014 Blood-borne pathogens raise the risk ... and procedures in place to counter this. However, it ... things tainted with menstrual blood are taken as seriously. ... more sanitary way to handle tampons and menstrual pads ... Sonora, Calif. , He then created a prototype of ...
(Date:11/27/2014)... Nov. 26, 2014 (HealthDay News) -- Most babies and ... cold, the U.S. Food and Drug Administration says. ... given to children younger than 2 because they could ... warned. American adults average about three colds a ... get a cold, parents might want to give them ...
(Date:11/27/2014)... November 27, 2014 Jeffrey Carlini ... in the Charlotte area providing audits, reviews, compilations, ... to businesses of varying size across numerous industries. ... to meet all of their accounting and tax ... the QuickBooks ProAdvisor Program. When asking Mr. Carlini ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... A Cochrane Systematic Review has concluded,Spraying salty water (saline) ... pain and congestion that accompany long-term infections of ... of people experience persistent infection of the nasal passages ... recommend spraying saline into the nose to relieve symptoms, ...
... (FDA) has approved the first artificial cervical (neck) disc for ... the most common causes of neck and arm pain. ... manufactured by Medtronic Sofamor Danek of Memphis. ,The ... degenerative disc disease now will have another surgical option for ...
... found that the chance of successfully quitting can be ... their stay, and then have at least one month ... in to hospital provides an opportunity to stop smoking. ... has to stop temporarily while in hospital. People who ...
... a dose of 20 mg per day can help people ... help prevent the weight gain that so often accompanies attempts ... was not shown to be effective. ,Smoking tobacco ... the endocannabinoid system, part of the hormonal control mechanism in ...
... that a chemical compound found in turmeric may help ... memory . ,Researchers isolated the compound 'bisdemethoxycurcumin' ... system cells that defend the body against infections and ... infuse this compound into patients and treat the incurable ...
... More than a year after President Bush unveiled a plan ... still has limited capacity to detect a disease outbreak ... has also decided that it will not close the borders ... Says Dr. Rajeev Venkayya, special assistant to the president for ...
Cached Medicine News:Health News:FDA Approves First Artificial Cervical Disc 2Health News:Hospital Provides an Oppurtunity to Quit Smoking 2Health News:20 Mg Rimonabant Per Day may Help to Quit Smoking 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
Surgical drill bits, twist drills, HSS. Available in various sizes....
... When viewed through the enclosed ... provide a standard screening devise for ... tested. With normal stereo perception, the ... page in 3D. The test includes ...
... a versatile new test providing the broadest ... book. The Multi-Target Stereo test can be ... binocularity, stereopsis, visual attention, form and depth ... version includes a pair of high quality ...
... Stereotest consists of three test plates(6mm, 3mm, and ... a range of 600 - 15 seconds. No ... only be detected if stereopsis is present. Test ... of the patient learning the correct answer. Large ...
Medicine Products: